Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Thrombosis of the transplanted pancreas is a common and often catastrophic event. Predisposing factors include the hypercoagulable state of many patients with diabetic renal failure, preservation-related graft endothelial injury, and low-velocity venous flow. Clinical management includes optimization of modifiable risk factors, controlled anticoagulation, graft monitoring, and early therapeutic intervention.

Original publication

DOI

10.1097/TP.0b013e3181eb2ea0

Type

Journal article

Journal

Transplantation

Publication Date

15/10/2010

Volume

90

Pages

705 - 707

Keywords

Anticoagulants, Blood Flow Velocity, Diabetic Nephropathies, Endothelium, Humans, Pancreas Transplantation, Pancreatectomy, Splenic Vein, Thrombosis, Transplantation, Homologous